Background/Aims: Members of the SLC20 cotransporter family (PiT-1, PiT-2) are ubiquitously expressed in mammalian tissue and are thought to perform housekeeping functions for intracellular P i homeostasis as well as being implicated in vascular calcification and renal P i reabsorption. The aims of this study were to investigate the topology of a linker region in PiT-1 between the predicted 2 nd and 3 rd transmembrane domains and to investigate the functional consequences of cysteine substitutions in this region. Methods: Cysteines were substituted at 18 sites in the Xenopus PiT-1 isoform and the mutants were expressed in Xenopus laevis oocytes. Transport function of the mutants was investigated by 32 P tracer or two electrode voltage clamp before and after thiol modification of the novel Cys. Results: Exposure to the thiol reactive reagent resulted in diminished transport function for 7 mutants. The apparent accessibility of 5 of the mutated sites, estimated from the rate of functional thiol modification, was site-dependent. Cysteine substitution at some sites also altered the apparent affinity for P i and cation (Na + /Li + ) and substrate (phosphate/arsenate) selectivity, further underscoring the importance of this linker in defining PiT-1 transport characteristics. Conclusions: The external accessibility of a linker in PiT-1 was confirmed and sites were identified that determine substrate selectivity and transport function.
Introduction
Symporters belonging to two distinct solute carrier gene families (SLC20 and SLC34) mediate Na + -coupled transport of inorganic phosphate (P i ) in mammals. The gene products of the SLC34 family (NaPi-IIa, NaPi-IIb and NaPi-IIc) are responsible for P i absorption and reabsorption across the apical membranes of many epithelia, including kidney and small intestine, where they play essential roles in P i homeostasis (for review see [1] [2] [3] [4] ). Their transport properties have been extensively characterized by heterologous expression in Xenopus oocytes and a number of structure-function studies based on cysteine scanning and voltage-clamp fluorometry have been described (reviewed in [3] ). The gene products of the SLC20 family (SLC20A1 or PiT-1and SLC20A2 or PiT-2, also referred to as type III Na + / P i transporters) were initially identified as retroviral receptors and later shown to be Na + -coupled P i cotransporters [5] [6] [7] . In humans they have a broad tissue distribution at the RNA level [8] and are considered to be ubiquitously expressed, which suggested that they play a housekeeping role for P i homeostasis in cells. However, specific roles for SLC20 proteins have been reported: for example, P i transport mediated by PiT-1 most likely plays a role in providing P i for the formation of mineralized bone [9] [10] [11] , PiT-1 has been strongly implicated in calcification of vascular tissue in response to hyperphosphatemia [12] [13] [14] [15] [16] [17] and a transportindependent role for PiT-1 in the regulation of TNF-induced apoptosis was reported [18] . Importantly, PiT-2 has been localized to the apical membrane of renal proximal tubule cells in the mammalian kidney and displays a different regulatory response from the SLC34 family members to changes in dietary P i [19, 20] , although its precise role in renal P i handling is yet to be fully elucidated [21] . Most recently, a role for PiT-2 in the CNS has been identified, whereby mutations in human PiT-2 (SLC20A2) have been implicated in familial idiopathic basal ganglia calcification (Fahr's disease) [22, 23] .
An important functional distinction between SLC34 and SLC20 proteins is that the former preferentially transport divalent phosphate (HPO 4 2- ), whereas it is established that SLC20 proteins prefer monovalent phosphate (H 2 PO 4 -) [19, 24, 25] . Kinetic analyses of SLC20 proteins have revealed other functional differences such as pH sensitivity, substrate specificity and driving cations [19, [26] [27] [28] , thereby underscoring the potential for different functional roles in the physiological context. Like SLC34 proteins, no 3-D structural information is currently available for the SLC20 family members, however unlike the former, only limited structure-function studies have been performed on these transporters [26, [29] [30] [31] [32] . The secondary topology is predicted to contain 12 transmembrane domains with extracellularly orientated N-and C-termini [32] [33] [34] [35] (Fig. 1A) and some critical regions and sites important for the viral recognition function have also been identified [29, 30, 32, 36] . In addition, two studies have identified sites critical for transport function [29, 37] .
The current lack of detailed structure-function information specifically relating to SLC20 proteins as Na + /P i cotransporters prompted us to start with a systematic application of the substituted cysteine accessibility method (SCAM) [38] to one region of the PiT-1 protein that was shown to contain functionally important sites [31] . Based on topology predictions, this region should be at least partly accessible to the external medium (Fig. 1B) . Our findings confirm this prediction and we suggest that this region may play an important role in substrate coordination and selectivity.
site-directed mutagenesis kit (Stratagene Inc., La Jolla, CA, USA). The sequence was verified by sequencing (Microsynth, Switzerland), linearized with NotI and cRNA was synthesized in the presence of Cap analog using the T7 Message Machine kit (Ambion, Inc., Austin, TX, USA). Stage V-VI defolliculated oocytes from Xenopus laevis were isolated and maintained as described previously [40] . Oocytes were injected with 50 nl of cRNA (50 ng). Control oocytes were either injected with 50 nl of water or not injected. Oocytes were incubated at 16°C in modified Barth's solution, containing (in mM) 88 NaCl, 1 KC1, 0.41 CaCl 2 , 0.82 MgSO 4 , 2.5 NaHCO 3 , 2 Ca(NO 3 ) 2 , 7.5 HEPES, pH 7.4 adjusted with TRIS. The solution was supplemented with 5 mg/l doxycyclin.
Electrophysiology and radiotracer flux experiments were performed 2-5 days after injection. Each data set was obtained from at least two batches of oocytes from two different frogs.
Reagents and solutions
All standard reagents were obtained from either Sigma-Aldrich or Fluka (Buchs, Switzerland). 2-(trimethylammonium) ethylmethanethiosulfonate bromide (MTSET) was obtained from Toronto Research Chemicals. The solution compositions were as follows: Control superfusate (100Na) (in mM): 100 NaCl, 2 KCl, 1.8 CaCl 2 , 1 MgCl 2 , 10 HEPES, adjusted to pH 7.4 using TRIS. Choline solution (100Ch): as for 100Na with isosmotic substitution of 100 choline chloride. Lithium superfusate (100Li): as for 100Na with isosmotic substitution of LiCl. Substrate test solutions: P i was added from 1 M K 2 HPO 4 and KH 2 PO 4 stocks premixed to give the required pH (7.4). A similar procedure was used for arsenate.
Radiotracer uptake
Groups of oocytes (7-10 oocytes/group) were first allowed to equilibrate in uptake solution without tracer. After aspiration of this solution we added 100 µl uptake solution containing radiotracer ( 32 P) (Perkin Elmer, Switzerland). The uptake was allowed to proceed for 15-20 min before it was stopped by washing the oocytes 4 times with 4 ml ice-cold 100Ch solution containing 0.5 mM cold P i . Uptake of 32 P i alone was showing predicted transmembrane domains (TMDs) (numbered 1-12) and linker region between TMD2 and TMD3 where cysteine substitutions were made (inset). Shaded TMDs are PD1131 homology domains predicted to play an important role in transport function [32, 35] . In PiT-2, deletion of the light grey shaded region (L202-V517) encompassing the large intracellular loop and TMD 6, 7 results in impaired transport function and loss of retroviral function [32] , whereas deletion of the region P274-V517 results in loss of retroviral function only [32] . Approximate positions of the 17 native Cys residues for XlPiT-1 are indicated (filled circles). Inset : sites mutated to cysteines (filled circles) and location of a predicted N-glycosylation site (grey outlined circle). Sites in PiT-2 (SLC20A2), corresponding to Glu-87 and Asp-95 were identified by Bøttger and Pedersen to be important for transport function [31] .B) Hydrophobicity plot for the region up to the end of TMD5 (Protscale, according to Kyte-Doolittle hydrophobicity scale) [49] . Boxed region represents linker under investigation. Filled boxes: predicted TMDs. All numbering refers to XlPiT-1 sequence.
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Cellular Physiology and Biochemistry carried out using 100Na solution and 1 mM cold P i , to which 32 P i (specific activity 10-20 mCi/ mmol P i ) was added. After washing, oocytes were placed individually in a scintillation vial and lysed in 250 µl 10% SDS. 32 P i activities of individual oocytes were counted using a Packard Tri-Carb 2900TR scintillation counter.
Electrophysiology
Standard two-electrode voltage clamp hardware was used (GeneClamp, Model 500, Molecular Devices), or a laboratory-built clamp [41] . The voltage clamp hardware was controlled, and data were acquired, using pClamp 8-9 software (Molecular Devices), which also controlled valves for solution switching. At the onset of each experiment the oocyte was clamped to a holding potential (V h ) = -50 mV and superfused with 100Na solution. To measure P i -induced currents (I P i ), the superfusate was switched to one containing P i and the change in the holding current was monitored. When the current reached a steady-state data were acquired and the perfusate was switched back and washout of P i was monitored by observing the return of holding current to baseline.
Determination of apparent P i affinity
To determine the apparent affinity constant for P i (K 0.5 P i) the electrogenic response to different P i concentrations added to the 100Na control solution was measured at a defined membrane potential. Oocytes were voltage-clamped to V h = -60 mV and voltage steps were applied in the range -160 to +60 mV for typically 100 ms. To measure P i -induced currents (I P i ), the superfusate was switched from the control (100Na) solution to one containing a given concentration of P i and when the holding current had reached a steady-state, the voltage steps were repeated. The control data set was subtracted from the data set obtained in the presence of P i to give I P i for each [P i ] and test voltage. To control for response rundown (e.g. [19] ), each P i test application or the complete series was bracketed by a 1 mM P i measurement, which was used to correct the preceding data sets if necessary. Estimates of K 0.5 P i were obtained by fitting data with a form of the Michaelis-Menten equation given by:
where I P i max is the maximum current attainable, I OFF is a variable offset to account for reversal I P i at low [P i ]. To account for the differences in expression levels between individual oocytes, data obtained from each oocyte were normalized to I P i recorded at -100 mV with 100Na and 1 mM P i before fitting the data with Eqn. 1.
Thiol modification by MTS reagents
MTSET was prepared in a 1 M stock solution (water or DMSO), which was kept at -20°C until required and further diluted with water or DMSO to give 1000-fold concentrated experimental aliquots before adding to the 100Na superfusate to achieve the final concentration as indicated. For 32 P uptake assays, oocytes were incubated in MTSET for 5 min and washed for 1 min. For electrophysiology, MTSET was applied to the recording chamber by gravity feed via a 0.5-mm-diameter cannula positioned near the cell. To determine the apparent accessibility, MTSET at a predetermined concentration was applied for 1 min followed by washout. During incubation, oocytes were clamped at V h = -50 mV. After washout I P i in response to 1 mM P i at V h =-50 mV was again measured and the MTSET application was repeated. The fixed MTSET concentrations were chosen by pretesting to facilitate determination of the modification rate so that degradation of MTS reagent was minimised. The P i response remaining after each successive application of MTS reagent was measured and plotted as a function of the cumulative exposure time, normalized to the initial I P i . The data were fit with a single decaying exponential to determine the effective second order reaction constant using an equation of the form: (2) where I P i t is the P i -induced current after a cumulative exposure time t, I P i 0 is the initial P i -induced current, I P i ∞ is the P i -induced current at infinity, [MTS] is the concentration of MTS reagent (assumed to be in excess) and k* is the effective second order rate constant e.g. [38] . Ravera 
Results

Cysteine scanning mutagenesis in the first extracellular linker region of PiT-1
We substituted cysteines one by one at 18 sites in the predicted 1 st extracellular linker of Xenopus laevis clone of PiT-1 (XlPiT-1) (Fig. 1A) . This region was chosen, based on previous mutagenesis studies that indicated that it contains functionally important residues [31, 37] . Moreover, hydrophobicity analysis predicted that this region was largely hydrophilic and should be accessible from the external medium (Fig. 1B) . We expressed the mutant constructs in Xenopus laevis oocytes and assayed them for functional transport using 32 
P.
Oocytes for each mutant were divided into a control group incubated in 100Na alone and a group that was incubated for 5 min in 100Na together with the membrane impermeable methane thiosulfonate reagent, 2-(trimethylammonium)ethyl methane thiosulfonate bromide (MTSET) at 1 mM. After incubation, the oocytes were washed and the uptake assay was performed (see Materials and Methods). Fig. 2 shows the pooled data from two batches of oocytes from different donor animals. All constructs gave uptake levels that were at least 5-fold greater than that obtained from control, non-injected (NI) oocytes. For WT XlPiT-1, preincubation in MTSET did not result in a significant change in 32 P uptake. This suggested that either none of the 17 native cysteines of XlPiT-1 (Fig. 1A ) was located in a functionally sensitive site, or if that were not the case, they were inaccessible from the external medium. We obtained the same result for mutants for which a Cys was substituted at 11 sites: Lys-84, Glu-87, Thr-88, Gly-92, Asp-95 (Fig. 2) ; at Lys-91 and from Asn-100 through to Leu-105 (data not shown)). In contrast, for mutants containing a Cys substituted at 7 sites (Val-85, Ser-86, Arg-90, Leu-93, Iso-94, Val-96, Met-98), the expressing oocytes showed a significant decrease in 32 P uptake after preincubation in MTSET (Fig. 2) .
Determination of accessibility using electrophysiology
To better define the conditions under which the thiol modification took place and quantitate the accessibility of the substituted cysteines, we used the two-electrode voltage clamp (TEVC) to control the membrane potential during the modification reaction and assay the behavior of single oocytes. Fig. 3A shows pooled data for the dependence of P iinduced current (I P i ) on membrane potential (V) for the mutant V96C data before and after incubation in MTSET (1 mM for 3 min). This mutant showed an almost complete suppression 
of I P i , whereas for the uptake assay under non-voltage clamp conditions, we observed only 50% inhibition (Fig. 2) . We also confirmed that the Cys-modification was reversible: after treatment with MTSET a representative oocyte was removed from the recording chamber and incubated for 10 min in the reducing agent dithiothreitol DTT (10 mM). This resulted in 75% recovery of the original I P i -V response, which confirmed that altered transport activity was most likely a result of the Cys-modification (data not shown).
The Cys-modification reaction rate, used to estimate the accessibility of the cysteine, was determined by measuring the progressive change in I P i after repeated exposure of the oocyte to MTSET for 1 min intervals (see Materials and methods). Fig. 3B shows the response of a representative oocyte that expressed the mutant V96C with 10 µM MTSET applied for 1 min intervals. The oocyte remained voltage clamped at -50 mV throughout the assay. The normalized response plotted as a function of cumulative exposure time showed behavior that could be described by a single decaying exponential (Eqn 2). The exponential fitting procedure allowed us to estimate the effective 2 nd order rate of Cys-modification (k*) (Fig. 3C) according to a simplified model for Cys-modification [38] . The magnitude of this reaction rate may be interpreted as a measure of the accessibility of the cysteine from the extracellular milieu. For the 5 mutants that gave reliable electrogenic responses, we found that k* varied according to the site of substitution (Fig. 3D) . . Continuous lines are fits using Eqn 2. The MTSET concentrations were (in µM): 0.5 (I94C); 1 (V85C, R90C); 5 (S86C, V96C). D) Effective 2 nd order rate constant (k*) plotted logarithmically for each Cys-mutant. The constant was derived from exponential curve fits by dividing the exponent by the MTSET concentration used to perform the assay as indicated in C). Error bars are SEM reported by fit. Ravera 
Cys-mutagenesis alters substrate interactions
Cys-substitution was generally well tolerated with respect to basic transport function (Fig. 2) , however we could not exclude the possibility that the Cys-substitution itself had altered the transport kinetics. To investigate this, we first performed a P i -activation assay and determined the apparent affinity for P i (K 0.5 P i, Eqn 1) as a function of membrane potential for mutants that gave adequate electrogenic responses. Representative P i -activation data two mutants (S86C and E87C) that gave contrasting behavior from the WT are shown in Fig.  4A for a range of potentials. The voltage dependence of I max P i and K 0.5 P i predicted from the fits is shown in Fig. 4B , C respectively. Both mutants S86C and E87C showed a WT-like voltage dependence for the normalised I max P i (Fig. 4B ) with a characteristic curvilinear dependence on V as we have previously reported [19] . Uncertainties in the fit results arising from the incomplete saturation of the P i -activation could easily explain the deviations observed. In contrast their K 0.5 P i dependence on V (Fig. 4C) both deviated from the relatively voltage- insensitive WT characteristic at depolarizing potentials [19] . At V= 0 mV, K 0.5 P i for E87C was approximately 3-fold higher, whereas mutant S86C, which involved a conservative substitution, showed a significant decrease of ≈ 10-fold compared with the WT. At strong membrane hyperpolarization, the K 0.5 P i data for the mutants appeared to approach that of the WT (Fig. 4C) . The effect of Cys substitution on K 0.5 P i for all mutants examined is summarised in Fig. 4D , which shows K 0.5 P i at -100 mV and -20 mV. With the exception of S86C and K84C, all mutants showed a reduced apparent affinity for P i compared with the WT at these potentials.
Next we compared the behavior of two mutants (S86C and R90C) with respect to substrate specificity and voltage dependence. Two features were readily apparent. First, both S86C and R90C showed a more obvious curvilinear I-V behavior compared with the WT for P i activation at 1 mM P i . Second, we and others have reported that substitution of arsenate for P i also results in measurable transport activity by SLC20 proteins [19, 28] . Using 1 mM AsO 4 (pH 7.4) as the activating substrate added to 100Na resulted in a ≈60% reduction in electrogenic response for the WT PiT-1 (Fig. 5A, left panel) , whereas for mutant S86C the reduction was only 25% (at -100 mV) (Fig. 5A, centre panel) . In contrast, mutant R90C, which displayed a voltage dependence for I P i similar to S86C, showed a reversal of the AsO 4 -induced current for hyperpolarizing potentials at approximately -50 mV (Fig. 5A, right  panel) .
Finally, we compared the behavior of these mutants when Li + replaced Na + as the driving cation. The former has also been previously reported to act as a driving cation for In each panel, the data were normalized to the response to P i (1 mM) at -100 mV. Dashed line is used to compare response at -100 mV, 1 mM P i . Data pooled from 4 oocytes. B) Comparison of electrogenic response to P i with 100 mM Na + (filled squares) substituted equimolarly with Li (open squares) for WT (left panel), S86C (centre panel) and R90C (right panel). In each panel, the data were normalized to the response to P i (1 mM) and 100 mM Na + at -100 mV (same data set as in A)). Dashed line is used to compare response at -100 mV, 1 mM P i and 100 mM Na + . Data pooled from 4 oocytes. Ravera [6, 29, 42] . When Li + was substituted, equimolarly for Na + , the WT showed a significantly reduced electrogenic response to P i (Fig. 5B, left panel) ), whereas for S86C the cation substitution resulted in a 25% reduction (at -100 mV) (Fig. 5B, centre panel) . Moreover, R90C expressing oocytes showed a similar behavior to that observed for arsenate substitution, whereby I P i reversed direction at approximately -50 mV (Fig. 5B, right panel) .
Discussion
The aims of this study were twofold: (i) to investigate the topology in a specific region of the PiT-1 protein predicted to be an external linker by means of the cysteine scanning accessibility method (SCAM) and (ii) to identify functionally important sites resulting from Cys-substitution and subsequent thiol modification. SCAM has previously proven useful when applied to members of the type II Na + /P i cotransporter (SLC34 family) (for review see [3] ). An important caveat for its successful application is that only the substituted Cys should be the target of the thiol reaction. XlPiT-1 contains 17 native Cys (Fig. 1) and although the WT protein showed no apparent change in transport function when incubated in MTSET, we cannot exclude the possibility that for the mutants, the Cys-mutagenesis may have resulted in a unique conformational change that exposed one of the native Cys to the extracellular medium (e.g. [43] ). It was reported that a Cys-less PiT-1 has been synthesized for topology investigations in the context of identifying the virus receptor motif [34] , however in that study the protein was expressed in a fibroblast cell line and no assays were performed to confirm functional transport of P i . Given the lack of altered transport function for the WT and that for the mutants described in this study the reduction was site-dependent, we tentatively assume that only the substituted Cys were involved. Nevertheless, future structure-function studies on PiT-1 should involve removal of native Cys to confirm the validity of the present findings.
The choice of the 1 st extracellular linker region in PiT-1 was based on a previous report, that mutagenesis at two sites in this region of the human PiT-2 (Glu-68, corresponding to Glu-87 in XlPiT-1; and Asp-76 corresponding to Asp-95 in XlPiT-1) had a significant effect on PiT-2 transport function when the mutants were expressed in Xenopus oocytes [31] . We found that Cys-substitution at one of the two sites identified by Bøttger and Pedersen [31] (mutant E87C), was well tolerated and exhibited comparable uptake to the WT although its apparent P i affinity was reduced compared with the WT at depolarizing potentials (Fig. 4C) . In contrast, substitution at the other site (mutant D95C) resulted in significantly diminished uptake (Fig. 2) , in agreement with the PiT-2 study in which the native Glu was replaced by a Gln [31] . Without a means to quantitate the amount of protein expressed at the membrane, we are unable to conclude whether the reduced transport function that we observed for D95C resulted from a concomitantly smaller transport rate or membrane expression level. From the P i -activation data, the reduced apparent affinity for P i (Fig. 4D) could, in part, account for the observed behavior. What is certain is that for both these mutants there was insignificant change in uptake level after exposure to MTSET (Fig. 2) . This suggested that these sites are either not readily accessible to the external medium or, if accessible, the Cys-modification did not alter the ability of the protein to catalyse P i transport. In contrast, we found that Cys substitution at the neighboring site (Ser-86) was, like Glu-87, well tolerated (mutant S86C), but MTSET incubation resulted in significant loss of transport activity. Moreover, Cys-substitution at the sites neighboring Asp-95 (mutants I94C and V96C) was also well tolerated and showed control uptake levels approximately 50% of the WT. However, MTSET incubation led to significant loss of activity, which indicated that their transport function was severely compromised and, moreover, confirmed the accessibility of Cys to the external milieu at sites 94 and 96.
Our initial SCAM assay by means of 32 P uptake identified 6 sites for which MTSET exposure resulted in a loss of transport function and we turned to electrophysiological assays to investigate some features in more detail, where we could readily observe the thiol Ravera/Murer/Forster: Cysteine Scanning in PiT-1
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry modification reaction in real time and control the transport conditions. Interestingly, when the uptake results were compared with the results of the same construct under voltage clamp, we generally observed a larger reduction in transport activity for individually voltageclamped oocytes. In addition to the statistical variation inherent in the uptake assays, this discrepancy may arise because we performed the uptake assays under non-voltage clamp conditions. If the accessibility of the Cys were influenced by the membrane potential, this could affect the proportion of modified transporters. The TEVC assay allowed us to estimate the effective 2 nd order rate constant (k*) for 5 mutants that gave reproducible electrogenic responses to P i (Fig. 3D) . The estimates of k* were in the same range as we have previously reported for a comparable assay performed on the SLC34A1 protein (NaPi-IIa) [44] . For XlPiT-1, the assay revealed that sites Val-85 and Iso-94 showed significantly higher modification rate compared with the others, which suggested that these sites were more exposed to the aqueous environment. That their Cys-modification led to a compromised transport function further suggests that they may be close to or part of the substrate binding site(s). In summary, our SCAM findings suggest that the topology of this linker region is most likely not simply an "external" loop that is uniformly exposed to the extracellular milieu, but may indeed form part of a hydrophilic pore region in which substrates might be expected to interact and bind to the specific sites during the transport cycle. Additional experiments to test this hypothesis should include performing the Cysmodification assay at different holding potentials and in the complete absence of substrate or in the presence of Na + and P i . These manipulations would be expected to place the transporters in different conformations that would alter the accessibility of the substituted Cys if they were close to the substrate binding sites.
Further evidence in support of this speculation in the present study came from electrophysiological assays applied to two mutants that showed a significant loss of activity after thiol modification (S86C and R90C). Mutant S86C, which involved a conservative Ser to Cys substitution showed the same apparent affinity for P i as the WT at hyperpolarizing potentials, however its K 0.5 P i decreased by ≈10-fold at V=0 (Fig. 4C ). This suggested that the residue at this site was a critical determinant of voltage dependent substrate interactions with PiT-1. The Ser-Cys substitution at site 86 also increased the relative response to As, which further suggested that the mutagenesis had altered substrate coordination (Fig. 5A) . Moreover, substitution of Na + by Li + resulted in a significantly increased electrogenic activity compared with the WT (Fig. 5B) .
In contrast, removal of charge at site 90 (mutant R90C), increased the voltage dependency of I P i (like S86C), but this mutant could neither support elecrogenic cotransport by As with Na + as the driving cation nor by P i when Li + equimolarly replaced Na + . These findings indicated that the charge at this site was critical for substrate discrimination, although we observed only a small increase in K 0.5 P i for the R90C mutant compared with the WT (Fig. 4D) . It was also noteworthy that when Cys-90 was presumably modified by MTSET, electrogenic cotransport function was fully suppressed. MTSET is positively charged, but when covalently bound to a Cys, results in a bulkier side chain (122 Ǻ 3 versus 173 Ǻ 3 ) [45] , which further underscores the critical role this site plays in substrate coordination. Mutant R90C also showed a unique electrogenic behavior for both substrate replacement experiments: I P i showed a reversed with an apparent outward current for hyperpolarizing potentials (Fig. 5B) . This behavior was not observed in non-injected oocytes (data not shown) and suggests that the substrates do indeed interact with the protein, but the full cotransport cycle with net inward charge movement does not occur. This electrogenic response might be evidence of an uncoupled leak current that is suppressed during the cotransport cycle. Analogous behavior has been reported for SLC34A1 proteins for which an uncoupled leak can be detected using the P itransporter inhibitor phosphonoformic acid [46] , the sodium-coupled glucose cotransporter SGLT1 for which pflorizin is known to block a protein-associated uncoupled leak [47, 48] and other cation-coupled cotransporters. Presently there is no PiT-specific inhibitor available to investigate this phenomenon further in the SLC20 family. Ravera 
Conclusions
We have established that an extracellular linker in XlPiT-1 is accessible to the external medium and thereby confirmed previous topological predictions for the SLC20 family. Moreover, we have shown that this region contains amino acids that are critical for the unique transport kinetics of SLC20 proteins-in particular the apparent affinity for P i and the cation and P i /As discrimination. This information will pave the way for further studies to identify functionally important regions of the SLC20 proteins and may also be used to define sites for drug targeting, particularly as no specific inhibitor of SLC20 proteins is currently available.
